Synthesis and evaluation of 1,2,3-triazole for selective Pb(II) detection and cytotoxic effect on HepG2 Cancer cells
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026
DOI: 10.1016/j.saa.2025.127089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026. Verfasst von Virendra Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Institute of Technology, Kurukshetra, Haryana 136119, India. Hauptthemen laut MEDLINE: Triazoles, Lead, Fluorescent Dyes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Human Resource Development Centre, Council of Scientific And Industrial Research.
Abstract (Originalsprache)
Lead (Pb) is an extremely toxic heavy metal that causes various health problems if contaminated in foodstuffs through any segment of the environment. Highly sensitive, selective, portable, low detection limit, low cost and efficient fluorescence-based chemosensors are of much demanding for the detection of heavy metal ions like Pb(II). Hence with, a new 1,2,3-triazole based probe was synthesized via a click reaction between terminal alkyne as 1-(prop-2-yn-1-yl)indoline-2,3-dione and organic azide as 2-azido-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H- pyrazol-4-yl) acetamide. After successful characterization by FT-IR, NMR, and HR-MS data, absorption and emission response of the probe was examined using UV-Vis and fluorescence spectrum. The LOD and LOQ results (1.28 μM and 4.27 μM, respectively) indicated that the probe may be used for the detection of toxic Pb(II) ions. A 1:1 complex formation between the probe and metal ions as confirmed by Job's plot was supported by DFT results. Molecular docking showed its potential as an anticancer agent against Topoisomerase IIβ and results were fairly supported by in-vitro biological activity against the HepG2 human liver cancer cell line.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Institute of Technology, Kurukshetra, Haryana 136119, India.
- School of Applied Sciences, Om Sterling Global University, Hisar, Haryana 125001, India.
- Department of Chemistry, National Institute of Technology, Kurukshetra, Haryana 136119, India. Electronic address: rktittaliitd@nitkkr.ac.in.
- School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India; Department of Applied Sciences and Humanities, Model Institute of Engineering and Technology (Autonom…
- School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
- Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, 160012, India.
Förderung
- Council of Scientific and Industrial Research, India
- Human Resource Development Centre, Council of Scientific And Industrial Research
Zitieren
APA
Singh, V., Lal, B., Kumar, S., Tittal, R. K., Singh, G., Singh, J., & Yadav, D. (2026). Synthesis and evaluation of 1,2,3-triazole for selective Pb(II) detection and cytotoxic effect on HepG2 Cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.127089
Vancouver
Singh V, Lal B, Kumar S, Tittal RK, Singh G, Singh J, et al. Synthesis and evaluation of 1,2,3-triazole for selective Pb(II) detection and cytotoxic effect on HepG2 Cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026. doi:10.1016/j.saa.2025.127089
BibTeX
@article{Singh2026,
author = {Singh, Virendra and Lal, Bajrang and Kumar, Sachin and Tittal, Ram Kumar and Singh, Gurleen and Singh, Jandeep and Yadav, Deepak},
title = {Synthesis and evaluation of 1,2,3-triazole for selective Pb(II) detection and cytotoxic effect on HepG2 Cancer cells},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
doi = {10.1016/j.saa.2025.127089}
}
EUVIMED